ArticleOrganic process research & development2026
Toward Chromatography-Free Convergent Peptide Synthesis via Nanostar Sieving.
Article in Organic process research & development, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Liquid-phase peptide synthesis (LPPS) has emerged as a versatile and efficient method for assembling peptides, offering significant advantages in purity and yield. In this study, we investigate the application of organic solvent nanofiltration (OSN) technology in LPPS for peptide fragment assembly by Nanostar Sieving. We report how a nanostar support decorated with solubilizing polymers can be used to achieve solubility at concentrations of up to 40 mM of a 39-mer peptide. This is assembled from eight peptide fragments on an 8-arm, 20 kDa nanostar support. OSN enables effective removal of reagents, byproducts, and unreacted fragments after each coupling cycle, enhancing synthesis efficiency. A photolabile linker was incorporated into the support before fragment assembly, enabling periodic analysis without full global deprotection. The Rink amide linker facilitated the final cleavage of the synthesized peptide using standard global deprotection protocols. Following synthesis, OSN was employed to isolate the peptide from the support. In contrast to previous OSN-assisted peptide fragment assembly methods, which required chromatographic purification to remove unreacted fragments at the end of synthesis, nanostar sieving enables their removal during synthesis. The potential to eliminate the need for chromatography could lead to more efficient and scalable therapeutic peptide production.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.